[Fetal toxicity of angiotensin-II receptor antagonists].
We report a case of a newborn with an oligohydramnios, acute renal failure and ossification abnormalities. The role of maternal treatment of essential hypertension by angiotensin-II receptor antagonists is discussed in regard to the literature and pathophysiological data.
Payen
V
V
Service de Réanimation Pédiatrique et Néonatale, Hôpital Gatien-de-Clocheville, 49, boulevard Béranger, 37000 Tours.
Chemin
A
A
Jonville-Béra
A-P
AP
Saliba
E
E
Cantagrel
S
S
D058186:Acute Kidney Injury / Q000139:chemically induced*; D047228:Angiotensin II Type 1 Receptor Blockers / Q000009:adverse effects*; D001562:Benzimidazoles / Q000009:adverse effects*; D001713:Biphenyl Compounds; D005260:Female; D005315:Fetal Diseases / Q000139:chemically induced*; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D016104:Oligohydramnios / Q000139:chemically induced*; D011247:Pregnancy; D013777:Tetrazoles / Q000009:adverse effects*
D047228:Angiotensin II Type 1 Receptor Blockers; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D013777:Tetrazoles; C081643:candesartan